临床研发解决方案
Innovating at the speed of change.
Expect safety, quality and speed as we deliver the data package you need to bring your product to market.
Move with speed
In-study agility and real-time information allow us to rapidly react to challenges and recognize opportunities to accelerate your trial.
Connect with sites and patients
With 15,000+ investigators and 5,500+ sites in our network, our advanced patient recruitment engine drives high-speed enrollment.
Apply 30+ years of insights
Our world-class team brings the right mix of full service and FSP during your study and beyond.
Accelerate your product to market
当风险很高时，您需要一位经验丰富的点对点合作伙伴。 With your product's future on the line, our approach ensures that your projects are delivered within targets.
You're not merely looking for experts-you want the right team for your study.我们提供经验丰富的项目管理团队，为您的特定研究需求带来相应的科学和治疗专业知识。
Insights to drive decision-making
Real-time information helps us move quickly, anticipate risk and uncover opportunities to advance your study. With our distinct combination of digital innovation and data-driven insights, we can eliminate white space and meet critical timelines.
Supporting sites
研究者付现成本约占全部研究预算的一半。 Fortrea's global processes deliver efficient, timely and accurate invoicing, which helps you stay within 3 percent of your planned budget more than 90 percent of the time.
We will help you find the most appropriate study locations and the most qualified investigators to support target patient enrollment populations.通过我们的专有信息数据库，您可以让研究者更容易地从一开始就能帮助您实现患者招募目标。
A focus on patients
With a global network of sites and solutions to drive diversity and inclusion in clinical trials and protocol designs that incorporate our Voice of the Patient program, we develop clinical trial strategies that can be achieved with patients motivated to participate.
Invested in your diversity goals
As the U.S. FDA continues to intensify its focus on improving diversity in clinical trials, we are actively helping sponsors prepare their Diversity Action Plans. To date, Fortrea has led the way, completing ~15% of all Diversity Action Plans for the FDA.
We act as an extension of your team to support your diversity goals and inclusion practices in clinical trials. We're also gathering the FDA's feedback to better prepare for studies that will start once approval of a Diversity Action Plan before initiation of pivotal studies is mandated.
